09:00-09:20 | 등록 | |
---|---|---|
09:20-09:30 | 개회사 | 최응호 : 대한아토피피부염학회 회장 |
09:30-10:40 |
Free Communication |
박영립 : 순천향의대 구대원 : 을지의대 |
10:40-11:00 |
Coffee break |
|
11:00-12:25 |
Session 1 Breaking new ground in AD |
최응호 : 연세원주의대 손상욱 : 고려의대 |
From heterogeneous AD endotypes to minimal disease activity |
Kave Shams : University of Leeds, UK | |
Deep dive into the complexities of innate and adaptive immunity in AD |
이상은 : 연세의대 | |
The role of regulatory T cells in AD |
김현제 : 서울의대 | |
12:25-13:40 |
Group photo |
|
Luncheon symposium 평의원회의 |
박영민 : 가톨릭의대 | |
Recent evidence underscoring the value of enduring control with tralokinumab |
Raj Chovatiya : Northwestern University Feinberg School of Medicine, USA | |
13:40-14:30 |
Session 2 Comparative insights: AD and other skin diseases |
노주영 : 이화의대 이성열 : 순천향의대 |
Navigating crossroads in barrier dysfunction: ACD and AD |
신순영 : 건국의대 | |
Overlaps and distinctions: Cutaneous T-cell lymphoma vs. AD |
안지영 : 국립중앙의료원 | |
14:30-15:55 |
Session 3 Towards a better understanding of AD treatment |
김유찬 : 아주의대이지범 : 전남의대 |
The evidence on comorbidities in AD: What we know? |
Thomas Bieber University Hospital,Zürich, Switzerland | |
Breaking free from itch: Advanced treatment approaches for pruritus and prurigo in AD |
장용현 : 경북의대 | |
Unlocking therapeutic potential of biologics and JAK inhibitors |
신민경 : 경희의대 | |
15:55-16:10 |
Coffee break |
|
16:10-17:00 |
Session 4 Unraveling future therapeutic landscape for AD |
조상현 : 가톨릭의대이양원 : 건국의대 |
Identifying key biomarkers in AD: From hope to reality? |
이동훈 : 서울의대 | |
Recent discoveries and next-generation therapies in AD |
한태영 : 을지의대 | |
17:00-17:10 |
우수연제 시상 |
|
17:10 |
폐회사 |